3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Phase II Trial of Oral Idarubicin in Advanced Non-Small Cell Lung Cancer (NSCLC)

, , , , , , , & show all
Pages 409-411 | Published online: 11 Jun 2009

References

  • Hoffman P C, Bitran J D, Golomb H M. Chemotherapy of metastatic non small cell bronchogenic carcinoma. Sem Oncol 1983; 10: 111–122
  • Casazza A M, Di Marco A, Bonadonna G, et al. Effect of modifications in position 4 of the chromophore or in position 4′ of the aminosugar, on the antitumor activity and toxicity of daunorubi-cin and doxorubicin. Anthracyclines: Current Status and New Developments. Academic Press, New York 1980; 403–430
  • Casazza A M. Experimental evaluation of anthracycline analogs. Cancer Treat Rep 1979; 63: 835–844
  • Casazza A M, Bertazzoli C, Pratesi G, et al. Antileukemic activity and cardiac toxicity of 4-demethoxydaunorubicin (4-DMD) in mice. Proc Am Assoc Cancer Res and ASCO 1979; 20: 16
  • Di Marco A, Casazza A M, Pratesi G. Antitumor activity of 4-demethoxy-daunorubicin administered orally. Cancer Treat Rep 1977; 61: 893–894
  • Mountain C F. A new international staging system for lung cancer. Chest (Suppl) 1986; 89: 225–233
  • Miller A B, Hoogstraten B, Staquet M, et al. Reporting result of cancer treatment. Cancer 1981; 47: 207–214
  • Joss R A, Obrecht J P, Alberto P, et al. Phase II trial of 4-demethoxydaunorubicin in patient with non small cell lung cancer. Cancer Treat Rep 1984; 68: 563–564
  • Broggini M, Italia C, Columbo T, et al. Activity and distribution of IV and oral 4-demethoxydaunorubicin in murine experimental tumors. Cancer Treat Rep 1984; 68: 739–747
  • Kriss M G, Gralla R J, Kelsen D P, et al. Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer. Am J Clin Oncol 1985; 8: 377–379

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.